Gentaur Blinatumomab – Anti-CD19 / CD3E Bispecific Antibody

Gentaur Blinatumomab – Anti-CD19 / CD3E Bispecific Antibody

Connects CD19 on B-cells to CD3 on T-cells, enabling T-cell–mediated cytotoxicity. A leading tool for leukemia and lymphoma research models.

1.234.567,00 € 1234567.0 EUR 1.234.567,00 €

1.234.567,00 €

Diese Kombination existiert nicht.

In den Warenkorb

Geschäftsbedingungen
30-Tage-Geld-zurück-Garantie
Versand: 2-3 Geschäftstage